BMRI in early detection of breast cancer in patients with increased genetic risk: Our preliminary results

Journal of Experimental and Clinical Cancer Research

Volumn 21, Issue 3 SUPPL., 2002, Pages 125-130

  Trecate, G ^a,b   Vergnaghi, D ^a   Bergonzi, S ^a   De Simone, T ^a   Costa, C ^a   Spatti, G B ^a   Pasini, B ^a   Musumeci, R ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

BRCA1 2; Breast Cancer; Breast Magnetic Resonance Imaging (BMRI); Optimized Screening

Indexed keywords

AGED; BASAL METABOLIC RATE; BREAST CANCER; CANCER PATIENT; CANCER SCREENING; CANCER SUSCEPTIBILITY; CONFERENCE PAPER; COUNSELING; EARLY DIAGNOSIS; FEMALE; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY PREVENTION; PRIORITY JOURNAL;

ADULT; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MUTATION; SUBTRACTION TECHNIQUE; ULTRASONOGRAPHY, MAMMARY;

EID: 0036766817     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. National Cancer Institute. SEER cancer statistics rewiew, 1973-1995: section 4-breast. Female breast cancer: trends in SEER incidence and U.S. mortality. Available at: http://www-seer.ims.nci.nhi.gov/Publications/CSR7395/breast.pdf. Accessed February 2, 2000.
2. Linch H.T., Albano W.A., Danes B.S., et al.: Genetic predisposition to breast cancer. Cancer 53:612-622, 1984.
3. Chang-Claude J., Becher H., Hamann U., Schroder K.T.: Risikoabschatzung fur das familiare auftreten von brustkrebs. Zentralb Gynakol 117:423-434, 1995.
4. Bick U.: An integrated early detection concept in women with a genetic predisposition for breast cancer. Radiologe 37:591-6, 1997.
5. Miki Y., Swensen J., Shattuck-Eidens D., et al.: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71, 1994.
6. Wooster R., Bignell G., Lancaster J., et al.: Identification of the brast cancer susceptibility gene BRCA2. Nature 378:789-792, 1995.
7. Claus E.B., Schildkraut J.M., Thompson W.D., Risch N.J.: The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318-2324, 1996.
8. Easton D.F., Bishop D.T., Ford D., Crockford G.P., and Breast Cancer Linkage Consortium: Genetic linkage analysis in familiar breast and ovarian cancer: result from 214 families. Am. J. Hum. Genet. 52:678-701, 1993.
9. De Michele A., Weber B.L.: Inherited genetic factors. In: Harris J.R., Lippman M.E., Morrow M. et al.: Disease of the Breast. Philadelphia: Lippincott Williams and Wilkins 1999: 221-236.
10. Johannsson O.T., Idvall I., Anderson C. et al.: Tumor biological features of BRCA1 induced breast and ovarian cancer. Eur. J. Cancer 33:362-371, 1997.
11. Foulkes W.D., Wong N., Rozen F., Brunet J. S., Narod S.A.: Survival of patients with breast cancer and BRCA1 mutations. Lancet 351:1359-1360, 1998.
12. Hartmann L.C., Schaid D.J., Woods J.E. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. New England of Medicine 340:77-84, 1999.
13. Kuhl C.K., Schmutzler R.K., Leutner C.C. et al.: Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 215:267-279, 2000.
14. Grann B.R., Jacobson J.S., Whang W. et al.: Prevention with Tamoxifen or other hormones versus prophylatic surgery in BRCA1/2-positive women: a decision analysis. Cancer Journal from Scientific American 6:13-20, 2000.
15. Kuhl C.K., Mielcarek P., Klaschik S. et al.: Are signal time course data useful for differential diagnosis of enhancing lesions in dynamic breast MR imaging? Radiology 211:101-110, 1999.
16. Abbott D.W., Thompson M.E., Robinson-Benion C. et al.: BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA-repair. J. Biol. Chem. 274:188808-18812, 1999.
17. Sharan S.K., Morimatsu M., Albrecht U., et al.: Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA2. Nature 386:804-810, 1997.
18. Beemsterboer P.M., Warmerdam P.G., Boer R., de Koning H.J.: Radiation risk of mammography related to benefit in screening programmes: a favourable balance? J. Med. Screen 5:81-87, 1998.
19. Jackson V.: The role of US in breast imaging. Radiology 177:305-311, 1990.
20. Trecate G., Tesoro Tess J.T., Musumeci R. et al.: Lobular breast cancer: how useful is breast magnetic resonance imaging? Tumori 87(4):232-238, 2001.
21. Boetes C., Stoutjesdijk M.: MR imaging in screening women at increased risk for breast cancer. Magn. Reson. Imaging Clin. N. Am. 2:357-372, 2001.
22. Trecate G., Tesoro Tess JD., Vergnaghi D., Bergonzi S., De Simone T., Mariani G., Musumeci R.:Breast microcalcifications studied with high field 3D contrast enhanced MRI: more accuracy in the diagnosis of breast cancer. Tumori 88, 225-234, 2002.